Cell Thera to explore alternatives (Dealscape

Seattle cancer drugmaker Cell Therapeutics Inc. announced Monday, March 16, it had hired financial advisers to explore strategic alternatives and sold its 50% interest in cancer drug joint venture RIT Oncology LLC.

"The review process may include seeking additional partners or collaborators for the company's product development candidates, additional equity or debt financings or seeking further efficiencies in its operations," the company said in an earnings statement.

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

106 in-depth reports of M&A deals in the Pharmaceutical sector
18 articles related to Cell Theraputics
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Deutsche Bank
Birds Eye
Cadbury AG
Agrium Inc.
Skadden Arps
Revolution Money
Tandberg ASA
Aisling Capital
Ken Lewis
Natco

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? Cell Thera to explore alternatives Posted on March 18, 2009 7:40 AM Seattle cancer drugmaker Cell Therapeutics Inc. announced Monday, March 16, it had hired financial advisers to explore strategic alternatives and sold its 50% interest in cancer drug joint venture RIT Oncology LLC. "The review process may include seeking additional partners or collaborators for the company's product development candidates, additional equity or debt financings or seeking further efficiencies in its operations," the company said in an earnings statement. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button. Dig deeper, with Pipeline. 106 in-depth reports of M&A deals in the Pharmaceutical sector 18 articles related to Cell Theraputics 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Deutsche Bank Birds Eye Cadbury AG Agrium Inc. Skadden Arps Revolution Money Tandberg ASA Aisling Capital Ken Lewis Natco		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.